BioFactura develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs using a proprietary rapid-generation platform. With over 15 years of experience in process development and manufacturing, BioFactura is well-versed in developing expression vectors, cell lines, and in-process and release analytical assays, with dedicated laboratory space allocated for general research, analytical testing, and cGMP cell culture, fermentation, and purification.